Updates on medical treatment for neuroendocrine neoplasm
Neuroendocrine neoplasm (NEN) is a group of heterogeneous malignancies arising from neuroendocrine cells and peptidergic neurons. According to its cell differentiation, NEN can be divided into two distinct groups as well-differentiated neuroendocrine tumor (NET) and poorly-differentiated neuroendocr...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Editorial Office of China Oncology
2022-09-01
|
| Series: | Zhongguo aizheng zazhi |
| Subjects: | |
| Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/1666588218681-1318722736.pdf |
| _version_ | 1811192342085894144 |
|---|---|
| author | LIANG Yun, JI Shunrong, YU Xianjun, CHEN Jie |
| author_facet | LIANG Yun, JI Shunrong, YU Xianjun, CHEN Jie |
| author_sort | LIANG Yun, JI Shunrong, YU Xianjun, CHEN Jie |
| collection | DOAJ |
| description | Neuroendocrine neoplasm (NEN) is a group of heterogeneous malignancies arising from neuroendocrine cells and peptidergic neurons. According to its cell differentiation, NEN can be divided into two distinct groups as well-differentiated neuroendocrine tumor (NET) and poorly-differentiated neuroendocrine carcinoma (NEC). For advanced NEN, medication is the preferred treatment. In this article, we reviewed current clinical trials in medical treatment for NEN and aimed to provide treatment reference in clinical practice. |
| first_indexed | 2024-04-11T23:51:08Z |
| format | Article |
| id | doaj.art-7387238ac395464bbe63c529823ee779 |
| institution | Directory Open Access Journal |
| issn | 1007-3639 |
| language | English |
| last_indexed | 2024-04-11T23:51:08Z |
| publishDate | 2022-09-01 |
| publisher | Editorial Office of China Oncology |
| record_format | Article |
| series | Zhongguo aizheng zazhi |
| spelling | doaj.art-7387238ac395464bbe63c529823ee7792022-12-22T03:56:29ZengEditorial Office of China OncologyZhongguo aizheng zazhi1007-36392022-09-0132975776410.19401/j.cnki.1007-3639.2022.09.001Updates on medical treatment for neuroendocrine neoplasmLIANG Yun, JI Shunrong, YU Xianjun, CHEN Jie01. Center for Neuroendocrine Tumors, Department of Head, Neck and Neuroendocrine Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China;2. Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Pancreatic Cancer Institute, Fudan University, Shanghai Pancreatic Cancer Institute, Shanghai 200032, ChinaNeuroendocrine neoplasm (NEN) is a group of heterogeneous malignancies arising from neuroendocrine cells and peptidergic neurons. According to its cell differentiation, NEN can be divided into two distinct groups as well-differentiated neuroendocrine tumor (NET) and poorly-differentiated neuroendocrine carcinoma (NEC). For advanced NEN, medication is the preferred treatment. In this article, we reviewed current clinical trials in medical treatment for NEN and aimed to provide treatment reference in clinical practice.http://www.china-oncology.com/fileup/1007-3639/PDF/1666588218681-1318722736.pdf|neuroendocrine neoplasms|medicine|clinical trial |
| spellingShingle | LIANG Yun, JI Shunrong, YU Xianjun, CHEN Jie Updates on medical treatment for neuroendocrine neoplasm Zhongguo aizheng zazhi |neuroendocrine neoplasms|medicine|clinical trial |
| title | Updates on medical treatment for neuroendocrine neoplasm |
| title_full | Updates on medical treatment for neuroendocrine neoplasm |
| title_fullStr | Updates on medical treatment for neuroendocrine neoplasm |
| title_full_unstemmed | Updates on medical treatment for neuroendocrine neoplasm |
| title_short | Updates on medical treatment for neuroendocrine neoplasm |
| title_sort | updates on medical treatment for neuroendocrine neoplasm |
| topic | |neuroendocrine neoplasms|medicine|clinical trial |
| url | http://www.china-oncology.com/fileup/1007-3639/PDF/1666588218681-1318722736.pdf |
| work_keys_str_mv | AT liangyunjishunrongyuxianjunchenjie updatesonmedicaltreatmentforneuroendocrineneoplasm |